(Businesswire.com, May 3, 2016) -
CCM Hockey, which is owned by Adidas, announced a three-year extension of its partnership with the Neurotrauma Impact Science Laboratory (NISL) at the University of Ottawa. The collaborative research partnership ensures that CCM helmets are independently tested for safety and meet the facility's high standards. The extension underlines CCM's commitment to player safety and ongoing research and development within the sport of hockey.
For decades, the University of Ottawa's Neurotrauma Impact Science Laboratory has been a leader in the field of head trauma research. The laboratory's mandate is to contribute in a meaningful way to decreasing all types of head injury in sport. CCM first entered into a partnership with the Neurotrauma Impact Science Laboratory in 2011. Through highly advanced laboratory tests and simulations, this joint research and development partnership allows CCM to gain further knowledge on head protection impact management in the sport of hockey. Additionally, the equipment manufacturer is able to collaborate with the specialized research facility to test helmets and drive product innovation focused on player safety.
"Player safety is our top priority," said Jeff Dalzell, Vice President, Product Creation and Sourcing, CCM Hockey. "This is emphasized by our continued research collaboration with the Neurotrauma Impact Science Laboratory, as well as other prominent universities in various categories. We believe that the NISL measures for testing are unparalleled in sport, and we are serious about investing in research to ensure our products are developed and tested on the leading edge of science to meet high external standards."
"We are thrilled to be able to work with CCM Hockey," said Dr. Blaine Hoshizaki, Laboratory Director, Neurotrauma Impact Science Laboratory. "CCM shares our passion to continuously improve player safety through ongoing research and development."
CCM Hockey recently announced that it will launch the new Fitlite 3DS helmet this summer. The CCM Fitlite 3DS and CCM Resistance helmet lines were both tested by the Neurotrauma Impact Science Laboratory, and are certified by HECC in the United States, the CSA in Canada and EN directives in Europe.